PCMA to support Chairman Baucus’ efforts to find common ground and advance bipartisan legislation

NewsGuard 100/100 Score

Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement regarding the Senate Finance Committee health care “mark” released today by Chairman Max Baucus (D-Mont.):

“PCMA supports Chairman Baucus’ continuing efforts to find common ground and advance bipartisan legislation. We look forward to reviewing Chairman Baucus’ proposal in greater detail and working constructively with the Finance Committee. In particular, we are encouraged that the Finance Committee’s prescription-drug provisions appear to sustain the proven PBM delivery model. Pharmacy benefit managers (PBMs) have played a central role in driving down prescription-drug trend by 73 percent from 1999 to 2007 and we believe this model should be supported and expanded in any reform legislation that advances.”

“America’s PBMs are committed to helping policymakers advance meaningful health care legislation that expands coverage, reduces costs, and improves quality throughout the system. As part of this effort, PCMA believes strongly that any credible reform legislation must recognize and enhance the value that an integrated pharmacy benefit can provide to all Americans. Expanded pharmacy choices, greater flexibility in benefit design, and new generic alternatives – including biogenerics – are all critical components of a modernized health care system.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neurological Narratives: A Journey into Women's Brain Health Research